ClinicalTrials.Veeva

Menu

Pain After Laparoscopy Results From the Incision, Manipulation of the Abdominal Organs, and Retained CO2(Back Pain)

S

Sohag University

Status and phase

Unknown
Phase 2

Conditions

Post Operative Pain, Acute

Treatments

Drug: intraperitoneal Magnesium sulfate
Drug: intravenous magnesium sulfate

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Postoperative pain after laparoscopy may be localized pain resulting from incision due to many (two or three) punctures (somatic pain) or due to manipulation of the intra-abdominal organs as ovaries, uterus, omentum, and intestine (visceral pain) or shoulder and back pain caused by retained CO2 in the peritoneal cavity with its irritation effect on the diaphragm.Patients will be divided into two groups:

Intraperitoneal (IP) group (20 patients):They will receive 100 ml normal saline infused over 10 min immediately before the induction of anesthesia and then continuous infusion of 500 ml normal saline intraoperatively then intraperitoneal wash of 100 ml normal saline containing 30 mg/kg MgSO4 at the end of laparoscopy.

Intravenous (IV) group (20 patients):They will receive 100 ml normal saline containing MgSO4 30 mg/kg infused over 10 min immediately before the induction of anesthesia and then continuous infusion of 500 ml normal saline containing MgSO4 (8mg/kg) intraoperatively then intraperitoneal wash using 100 ml normal saline at the end of laparoscopy

Enrollment

44 estimated patients

Sex

Female

Ages

20 to 44 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

20-44 years old females, (ASA) class I-II

Exclusion criteria

  • Patient refusal
  • Allergy to MgSO4
  • Atrio-ventricular conduction abnormalities
  • Drug abuse
  • Renal or hepatic or cardiovascular dysfunction
  • Prior long-term treatment with calcium channel blockers or magnesium

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

44 participants in 2 patient groups

Intraperitoneal magnesium sulfate (IP) group
Active Comparator group
Description:
They will receive 100 ml normal saline infused over 10 min immediately before the induction of anesthesia and then continuous infusion of 500 ml normal saline intraoperatively then an intraperitoneal wash of 100 ml normal saline containing 30 mg/kg MgSO4 at the end of laparoscopy.
Treatment:
Drug: intraperitoneal Magnesium sulfate
Intravenous magnesium sulfate (IV) group
Active Comparator group
Description:
They will receive 100 ml normal saline containing MgSO4 30 mg/kg infused over 10 min immediately before the induction of anesthesia and then continuous infusion of 500 ml normal saline containing MgSO4 (8mg/kg) intraoperatively then intraperitoneal wash using 100 ml normal saline at the end of laparoscopy.
Treatment:
Drug: intravenous magnesium sulfate

Trial contacts and locations

1

Loading...

Central trial contact

Fouad Soliman, lecturer; Soliman

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems